Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2003 Jan 21;1002:680-4. doi: 10.1073/pnas.242735399.
Show Gene links
Show Anatomy links
Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.
Wilson FH
,
Kahle KT
,
Sabath E
,
Lalioti MD
,
Rapson AK
,
Hoover RS
,
Hebert SC
,
Gamba G
,
Lifton RP
.
???displayArticle.abstract???
Mutations in the serine-threonine kinases WNK1 and WNK4 [with no lysine (K) at a key catalytic residue] cause pseudohypoaldosteronism type II (PHAII), a Mendelian disease featuring hypertension, hyperkalemia, hyperchloremia, and metabolic acidosis. Both kinases are expressed in the distalnephron, although the regulators and targets of WNK signaling cascades are unknown. The Cl(-) dependence of PHAII phenotypes, their sensitivity to thiazide diuretics, and the observation that they constitute a "mirror image" of the phenotypes resulting from loss of function mutations in the thiazide-sensitive Na-Cl cotransporter (NCCT) suggest that PHAII may result from increased NCCT activity due to altered WNK signaling. To address this possibility, we measured NCCT-mediated Na(+) influx and membrane expression in the presence of wild-type and mutant WNK4 by heterologous expression in Xenopus oocytes. Wild-type WNK4 inhibits NCCT-mediated Na-influx by reducing membrane expression of the cotransporter ((22)Na-influx reduced 50%, P < 1 x 10(-9), surface expression reduced 75%, P < 1 x 10(-14) in the presence of WNK4). This inhibition depends on WNK4 kinase activity, because missense mutations that abrogate kinase function prevent this effect. PHAII-causing missense mutations, which are remote from the kinase domain, also prevent inhibition of NCCT activity, providing insight into the pathophysiology of the disorder. The specificity of this effect is indicated by the finding that WNK4 and the carboxyl terminus of NCCT coimmunoprecipitate when expressed in HEK 293T cells. Together, these findings demonstrate that WNK4 negatively regulates surface expression of NCCT and implicate loss of this regulation in the molecular pathogenesis of an inherited form of hypertension.
Cormack,
FACS-optimized mutants of the green fluorescent protein (GFP).
1996, Pubmed
Cormack,
FACS-optimized mutants of the green fluorescent protein (GFP).
1996,
Pubmed
Damke,
Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.
1994,
Pubmed
Ellison,
Thiazide-sensitive sodium chloride cotransport in early distal tubule.
1987,
Pubmed
Gamba,
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter.
1993,
Pubmed
,
Xenbase
Gamba,
Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney.
1994,
Pubmed
,
Xenbase
Hanks,
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.
1995,
Pubmed
Hoover,
N-Glycosylation at two sites critically alters thiazide binding and activity of the rat thiazide-sensitive Na(+):Cl(-) cotransporter.
2003,
Pubmed
,
Xenbase
Kim,
The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein.
1998,
Pubmed
Lifton,
Molecular mechanisms of human hypertension.
2001,
Pubmed
Mayan,
Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
2002,
Pubmed
Mosterd,
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
1999,
Pubmed
Náray-Fejes-Tóth,
sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels.
1999,
Pubmed
,
Xenbase
PAVER,
HYPERTENSION AND HYPERPOTASSAEMIA WITHOUT RENAL DISEASE IN A YOUNG MALE.
1964,
Pubmed
Plotkin,
Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney.
1996,
Pubmed
Schambelan,
Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
1981,
Pubmed
Simon,
Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.
1996,
Pubmed
Slepnev,
Tandem arrangement of the clathrin and AP-2 binding domains in amphiphysin 1 and disruption of clathrin coat function by amphiphysin fragments comprising these sites.
2000,
Pubmed
Take,
Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism.
1991,
Pubmed
Terada,
Thiazide-sensitive NaCl absorption in rat cortical collecting duct.
1990,
Pubmed
Wilson,
Human hypertension caused by mutations in WNK kinases.
2001,
Pubmed
Zhang,
Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf.
2001,
Pubmed